<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
<responseDate>2026-06-26T03:45:25Z</responseDate>
<request identifier="oai:icatplus.esrf.fr:inv/2114571794" metadataPrefix="oai_datacite" verb="GetRecord">https://icatplus.esrf.fr/oaipmh/request</request>
<GetRecord>
<record>
<header>
<identifier>oai:icatplus.esrf.fr:inv/2114571794</identifier>
<datestamp>2025-06-06T06:00:11.597Z</datestamp>
</header>
<metadata>
<oai_datacite xmlns="http://schema.datacite.org/oai/oai-1.1/" xsi:schemaLocation="http://schema.datacite.org/oai/oai-1.1/ http://schema.datacite.org/oai/oai-1.1/oai.xsd">
<schemaVersion>4.2</schemaVersion>
<datacentreSymbol>EI</datacentreSymbol>
<payload>
<resource xmlns="http://schema.datacite.org/meta/kernel-4.2/" xsi:schemaLocation="http://schema.datacite.org/meta/kernel-4.2/ http://schema.datacite.org/meta/kernel-4.2/metadata.xsd">
<identifier identifierType="DOI">10.15151/ESRF-ES-2114571794</identifier>
<creators>
<creator>
<creatorName nameType="Personal">Youssef BOUARGALNE</creatorName>
<givenName>Youssef</givenName>
<familyName>Bouargalne</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-0129-814X</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">NICOLAS CARAMELLO</creatorName>
<givenName>Nicolas</givenName>
<familyName>Caramello</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0003-0025-0213</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Youssef BOUARGALNE</creatorName>
<givenName>Youssef</givenName>
<familyName>Bouargalne</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-0129-814X</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Simone ROSSI</creatorName>
<givenName>Simone</givenName>
<familyName>Rossi</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0009-0006-2869-5627</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Simone ROSSI</creatorName>
<givenName>Simone</givenName>
<familyName>Rossi</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0009-0006-2869-5627</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Adriana Erica MIELE</creatorName>
<givenName>Adriana Erica</givenName>
<familyName>Miele</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-4637-2606</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Adriana Erica MIELE</creatorName>
<givenName>Adriana Erica</givenName>
<familyName>Miele</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-4637-2606</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Nushin AGHAJARI</creatorName>
<givenName>Nushin</givenName>
<familyName>Aghajari</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-2245-2679</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Nushin AGHAJARI</creatorName>
<givenName>Nushin</givenName>
<familyName>Aghajari</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-2245-2679</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Christophe GUILLON</creatorName>
<givenName>Christophe</givenName>
<familyName>Guillon</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0001-6378-3303</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Christophe GUILLON</creatorName>
<givenName>Christophe</givenName>
<familyName>Guillon</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0001-6378-3303</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Hugo LEBRETTE</creatorName>
<givenName>Hugo</givenName>
<familyName>Lebrette</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-8081-181X</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Hugo LEBRETTE</creatorName>
<givenName>Hugo</givenName>
<familyName>Lebrette</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-8081-181X</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Xavier ROBERT</creatorName>
<givenName>Xavier</givenName>
<familyName>Robert</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-6174-8595</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Xavier ROBERT</creatorName>
<givenName>Xavier</givenName>
<familyName>Robert</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0002-6174-8595</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Aline PARPINEL</creatorName>
<givenName>Aline</givenName>
<familyName>Parpinel</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Sebastien VIOLOT</creatorName>
<givenName>Sebastien</givenName>
<familyName>Violot</familyName>
<nameIdentifier nameIdentifierScheme="ORCID">0000-0001-7749-9207</nameIdentifier>
</creator>
<creator>
<creatorName nameType="Personal">Aline PARPINEL</creatorName>
<givenName>Aline</givenName>
<familyName>Parpinel</familyName>
</creator>
</creators>
<titles>
<title>Macromolecular Crystallography in Bordeaux/Lyon/Toulouse : IECB IBGC CBMN / IBCP-MMSB ICBMS / IPBS LMGM</title>
</titles>
<publisher>Example Institute</publisher>
<publicationYear>2028</publicationYear>
<resourceType resourceTypeGeneral="Collection">Data from large facility measurement</resourceType>
<dates>
<date dateType="Collected">2025-06-05T15:00:00Z/2025-06-06T06:00:00Z</date>
<date dateType="Accepted">2025-06-06T06:00:00Z</date>
</dates>I<rightsList>
<rights rightsIdentifier="CC-BY-4.0" rightsURI="https://creativecommons.org/licenses/by/4.0">CC-BY-4.0</rights>
</rightsList>
<descriptions>
<description descriptionType="Abstract">The different research teams who are part of this BAG are located in Bordeaux, Lyon and Toulouse. They are mainly working on worldwide health concerns or biotechnological relevant projects. In more details, infectiology, molecular assemblies, biosynthetic pathways or glycobiology are their main research axises. Important results have been obtained so far regarding the development of new therapeutic strategies against several infectious diseases or regarding plastic bioremediation. In order to go further into details of all these studies, access to ESRF facilities is a requirement.</description>
</descriptions>
</resource>
</payload>
</oai_datacite>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
